Is serum calcium a biomarker of fatal prostate cancer?

Future Oncology

Volumn 5, Issue 5, 2009, Pages 577-580

  Schwartz, Gary G ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

APOPTOSIS; CALCIUM BLOOD LEVEL; CANCER CELL; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; DISEASE MARKER; EDITORIAL; FATALITY; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; BLOOD; CANCER REGISTRY; MALE; PROSTATE TUMOR;

CALCIUM; HUMANS; MALE; PROSTATIC NEOPLASMS; SEER PROGRAM; TUMOR MARKERS, BIOLOGICAL;

EID: 69849089794     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.09.37     Document Type: Editorial

References (20)

1. Agrawal S, Dunsmuir WD: Molecular markers in prostate cancer. Part I: predicting lethality. Asian J. Androl. 11, 14-21 (2009).
2. Klotz L: Active surveillance for prostate cancer: for whom? J. Clin. Oncol. 23, 8165-8169 (2005).
3. O'Donnell H, Parker C: What is low-risk prostate cancer and what is its natural history? World J. Urol. 26, 415-422 (2008).
4. Ketchandji M, Kuo Y-F, Shaninian VB, Goodwin JS: Cause of death in older men after the diagnosis of prostate cancer. J. Am. Geriatric. Soc. 57, 24-30 (2009).
5. Michaelson MD, Cotter SE, Gargollo PC et al.: Management of complications of prostate cancer treatment. CA Cancer J. Clin. 58, 196-213 (2008).
6. Schwartz GG: Vitamin D and the epidemiology of prostate cancer. Sem. Dialysis 18, 276-289 (2005).
7. Skinner HG, Schwartz GG: Serum calcium and incident and fatal prostate cancer in the National Health and Nutrition Examination Survey. Cancer Epidemiol. Biomarkers Prev. 17, 2302-2305 (2008).
8. Skinner HG, Schwartz GG: A prospective study of total and ionized serum calcium and fatal prostate cancer. Cancer Epidemiol. Biomarkers Prev. 18, 575-578 (2009).
9. Lin KI, Chattopadhyay N, Bai M et al.: Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem. Biophys. Res. Commun. 249, 325-331 (1998).
10. + channels (IKca1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 28(15), 1792-1806 (2009).
11. Liao J, Schneider A, Datta NS, McKauley LK: Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res. 77, 9065-9073 (2006).
12. Schwartz GG: Prostate cancer, serum parathyroid hormone and the progression of skeletal metastases. Cancer Epidemiol. Biomarkers Prev. 17, 478-483 (2008).
13. Tseng M, Breslow RA, Graubard BJ, Ziegler RG: Dairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Expidemiologic Follow-up Study cohort. Am. J. Clin. Nutr. 81, 1147-1154 (2005).
14. Gao X, LaValley MP, Tucker KL: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis. J. Natl Cancer Inst. 97, 1768-1777 (2005).
15. Jorde R, Sundsfjord J, Bønaa KH: Determinants of serum calcium in men and women. The Tromsø Study. Eur. J. Epidemiol. 17, 117-1123 (2001).
16. Muldowney WP, Mazbar SA: Rolaids-yogurt syndrome: a 1990s version of milk-alkali syndrome. Am. J. Kidney Dis. 27, 270-272 (1996).
17. Ladenson JH, Bowers GN Jr: Free calcium in serum. II. Rigor of homeostatic control, correlations with total serum calcium, and review of data on patients with disturbed calcium metabolism. Clin. Chem. 19, 575-582 (1973).
18. Andriole GL, Grubb RL 3rd, Buys SS et al.: Mortality results from a randomized prostate-cancer screening trial. N. Engl. J. Med. 360, 1310-1319 (2009).
19. Schwartz GG: Vitamin D and intervention trials in prostate cancer: From theory to therapy. Ann. Epidemiol. 19, 96-102 (2009).
20. Tucci M, Mosca A, Lamanna G et al.: Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. Prostate Cancer Prostatic Dis. 12, 94-99 (2009).